Clinical Trial Update: A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing two insulins (Insulin 287 and Insulin Glargine) in type 2 diabetes patients naive to insulin shows completed status with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin 287 (NNC0148-0287 C)
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2021-01-08